Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nuvation Bio (NUVB)
NYSE:NUVB
Holding NUVB?
Track your performance easily
Nuvation Bio (NUVB) Ownership Overview
27.30% Insiders
10.65% Mutual Funds
27.69% Other Institutional Investors
7.24% ETFs
27.13% Public Companies and
Individual Investors
The ownership structure of Nuvation Bio (NUVB) stock is a mix of institutional, retail, and individual investors. Approximately 45.58% of the company’s stock is owned by Institutional Investors, 27.30% is owned by Insiders, and 27.13% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 13, 2024 | Junyuan Jerry Wang Ceo, Anheart Therapeutics Ltd,director | xxxxxxxxxxxxx | $162883 |
| Oct 10, 2024 | Mashal Robert Director | xxxxxxxxxxxxx | $220000 |
| Jun 26, 2024 | Xiangmin Cui Director | xxxxxxxxxxxxx | $825348 |
| Jun 25, 2024 | Xiangmin Cui Director | xxxxxxxxxxxxx | $1492385 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $161218 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $183021 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1492546 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $29935658 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 58,281,054 | Insider | 17.32% | 157,358,846 | |
| 25,954,439 | Insider | 7.71% | 70,076,985 | |
| 14,132,421 | Institution | 4.20% | 38,157,537 | |
| 13,072,340 | Institution | 3.88% | 35,295,318 | |
| 10,315,038 | Institution | 3.06% | 27,850,603 | |
| 10,042,294 | Institution | 2.98% | 27,114,194 | |
| 8,457,071 | Institution | 2.51% | 22,834,092 | |
| 6,112,686 | Insider | 1.82% | 16,504,252 | |
| 3,811,513 | Institution | 1.13% | 10,291,085 | |
| 3,123,214 | Institution | 0.93% | 8,432,678 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,132,421 | Institution | 4.20% | 38,157,537 | |
| 8,457,071 | Institution | 2.51% | 22,834,092 | |
| 3,123,214 | Institution | 0.93% | 8,432,678 | |
| 2,051,818 | Institution | 0.61% | 5,539,909 | |
| 1,587,440 | Institution | 0.47% | 4,286,088 | |
| 1,235,228 | Institution | 0.37% | 3,335,116 | |
| 870,755 | Institution | 0.26% | 2,351,039 | |
| 761,442 | Institution | 0.23% | 2,055,893 | |
| 644,704 | Institution | 0.19% | 1,740,701 | |
| 504,523 | Institution | 0.15% | 1,362,212 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,128,150 | Institution | 1.82% | 13,543,212 | |
| 4,929,872 | Institution | 1.46% | 13,310,654 | |
| 2,436,770 | Institution | 0.72% | 5,385,262 | |
| 1,753,809 | Institution | 0.52% | 4,735,284 | |
| 1,588,385 | Institution | 0.47% | 4,288,640 | |
| 817,931 | Institution | 0.24% | 2,110,262 | |
| 827,720 | Institution | 0.25% | 1,829,261 | |
| 482,166 | Institution | 0.14% | 1,243,988 | |
| 417,120 | Institution | 0.12% | 1,126,224 | |
| 412,145 | Institution | 0.12% | 1,112,792 |
FAQ
Who Owns Nuvation Bio (NUVB)?
According to the latest TipRanks data, approximately 27.69% of the company's stock is held by institutional investors, 27.30% is held by insiders, and 27.13% is held by retail investors.
What percentage of Nuvation Bio (NUVB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 27.69% of Nuvation Bio (NUVB) stock is held by institutional investors.
What percentage of Nuvation Bio (NUVB) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.13% of Nuvation Bio (NUVB) stock is held by retail investors.
Who owns the most shares of Nuvation Bio (NUVB)?
David Hung owns the most shares of Nuvation Bio (NUVB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.